French President Emmanuel Macron accused Elon Musk on Monday of “supporting a new reactionary international” and interfering in the elections of other countries, such as Germany.
“Ten years ago, if we had been told that the owner of one of the largest social networks in the world would support a new reactionary international and intervene directly in elections, including Germany, who would have imagined it?” he asked during a speech before the annual conference of French ambassadors.
Macron warned of the “uncertainty” that lives a world increasingly in “disorder”, marked by the return of imperial impulses, the questioning of information and knowledge and the “very violent” questioning of humanism.
He warned that there is “an international of reactionaries” that represents “great private financial interests”, which takes advantage of the fact that “our liberal democracies have not been sufficiently effective” in protecting the middle class.
“We must achieve an agenda for the defense of democracy”
“We must achieve an agenda for the defense of democracy,” with counter-powers, and he also warned that large technology companies, while offering new possibilities, are also making States feel threatened by their growing power.
Advertisement
20260101_dengue_cubeta_728x90
20260101_dengue_barril_728x90
20260101_dengue_llanta_728x90
20260101_dengue_pileta_728x90
20260224_estafa_mh_728x90
20260212_constancia_pagos_mh_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
Faced with this situation, he reached out to the president-elect of the United States, Donald Trump, assuring that the future tenant of the White House “kinds that he has a solid ally” in France.
He added that Trump, who will take office in two weeks, has “a lucid ambition about the transatlantic relationship” between the US and Europe, and recalled that France “knew how to work” with Trump during his first term in 2016-2020.
Macron also acknowledged that “if you are weak and defeatist, there is little chance of being respected by President Trump’s United States.”
The French head of state extended his criticism of Russia and Iran. Regarding Russia, he said that it “has changed” in the way it exerts its “aggressiveness towards Europeans,” and recalled its political and electoral interference last year in Romania, Moldova, Georgia and Armenia.
Macron on Ukraine: “There is no quick and easy solution”
He also accused Moscow of “de facto globalizing” the war in Ukraine, which in his opinion is one of the great strategic challenges for Europe.
Advertisement
20260101_dengue_cubeta_728x90
20260101_dengue_barril_728x90
20260101_dengue_llanta_728x90
20260101_dengue_pileta_728x90
20260224_estafa_mh_728x90
20260212_constancia_pagos_mh_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
Macron acknowledged that “there is no quick and easy solution to that conflict,” but also recalled that there will be no solution without the Ukrainians, something that Europe would not accept either.
And about Iran, he said that his ballistic program “threatens European territory” and that he has been involved in the Russian invasion of Ukraine, as well as in the conflicts in the Middle East.
“The Iranian issue is one of the main ones that we will deal with with the new US Administration,” he summarized.
Macron also warned about the “very important” risk of “regression” in the international fight against climate change, for which he said he is responsible for the recent disasters in Spain and in the French department of Mayotte.
“There is no justification for the continuation of Israel’s military operations”
On Gaza, he said that “there is no justification for the continuation of Israel’s military operations” in that territory and said that this year must mark the progress for the materialization of Palestinian aspirations.
Advertisement
20260101_dengue_cubeta_728x90
20260101_dengue_barril_728x90
20260101_dengue_llanta_728x90
20260101_dengue_pileta_728x90
20260224_estafa_mh_728x90
20260212_constancia_pagos_mh_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
The French president also focused on international trade, which in his opinion must be “rethought”, because Europeans “have been too naive”, and gave as an example the dispute with China over electric cars.
“If there is no loyalty in trade, it is not possible to produce competitively in Europe,” he said, so he asked to “defend European production capacity at every step of the value chain.”
India Approves New Dengue Vaccine as Global Cases Continue to Rise
India has approved a new dengue vaccine as health authorities seek to strengthen prevention efforts against a mosquito-borne viral disease that affects millions of people worldwide every year.
According to the World Health Organization (WHO), half of the global population is currently at risk of contracting dengue, which causes between 100 million and 400 million infections annually.
Since 2021, India has recorded more than one million dengue cases, including at least 1,500 deaths.
The virus can cause high fever, severe headaches, muscle pain, nausea, skin rashes and, in rare cases, internal bleeding and death.
The vaccine, authorized by India’s Central Drugs Standard Control Organization (CDSCO), was developed by Japanese pharmaceutical company Takeda. The Indian Health Ministry said the vaccine is recommended in two doses for people between 4 and 60 years old.
Advertisement
20260101_dengue_cubeta_728x90
20260101_dengue_barril_728x90
20260101_dengue_llanta_728x90
20260101_dengue_pileta_728x90
20260224_estafa_mh_728x90
20260212_constancia_pagos_mh_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
The treatment has already been approved by health authorities in around 40 countries worldwide.
Meanwhile, Indian pharmaceutical company Panacea Biotec has begun the final phase of clinical trials for a single-dose dengue vaccine, aiming to provide another prevention option against the disease.
Brazil recently announced the suspension of the use of another single-dose dengue vaccine developed in the country after two suspected deaths were reported.
U.S. Sends First Humanitarian Aid Flight to Cuba Amid Ongoing Tensions Between Both Governments
The United States announced Tuesday the dispatch of a humanitarian aid flight to Cuba as part of a $100 million assistance package proposed by Secretary of State Marco Rubio in May.
The flight departed from Miami with the support of Catholic Relief Services, according to a statement from the U.S. State Department.
The administration of President Donald Trump, which has maintained restrictions on oil supplies to the island and tightened sanctions against the Cuban government, had initially announced humanitarian assistance in November following the devastating impact of Hurricane Melissa.
In February, amid rising tensions between Washington and Havana, Rubio announced an increase in aid while continuing to criticize the Cuban government.
The U.S. secretary of state accused Cuba’s communist authorities of obstructing the distribution of assistance. Washington has insisted that the aid be delivered through the Catholic Church to ensure it reaches Cuban citizens directly.
Advertisement
20260101_dengue_cubeta_728x90
20260101_dengue_barril_728x90
20260101_dengue_llanta_728x90
20260101_dengue_pileta_728x90
20260224_estafa_mh_728x90
20260212_constancia_pagos_mh_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
The Cuban government, meanwhile, has blamed the U.S. oil blockade for making the distribution of humanitarian assistance significantly more difficult.
The aid shipment comes as relations between the two countries remain strained, with disagreements continuing over sanctions, energy supplies and the management of humanitarian support.
Controversial Pesticide Law Passes in France, Sparking Ecological Concerns and Ministerial Fallout
The French Parliament on Tuesday approved a highly controversial agricultural law that allows certain farmers to use two pesticides considered harmful to bees, substances that had been banned in France but remain authorized in the European Union.
After the National Assembly, the lower house of Parliament, approved the agricultural bill in the early hours of Tuesday, the Senate gave its final approval with a vote of 214 in favor and 111 against, officially adopting the measure.
Following the decision to reintroduce the use of acetamiprid and flupyradifurone, the office of Environment Minister Monique Barbut announced that she would soon submit her resignation.
Supporters of the measure argue that French producers of sugar beets, apples and hazelnuts need access to these insecticides — banned in France since 2018 and 2019, respectively — to remain competitive with European farmers in other countries where the products are still allowed.
Opponents, including environmental groups, argue that the substances pose serious risks to bees and could also threaten human health.
Advertisement
20260101_dengue_cubeta_728x90
20260101_dengue_barril_728x90
20260101_dengue_llanta_728x90
20260101_dengue_pileta_728x90
20260224_estafa_mh_728x90
20260212_constancia_pagos_mh_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
“Let us be proud of the work that has been done,” said Senator Laurent Duplomb of the conservative Republicans party, one of the main supporters of the measure.
The vote came after France’s Constitutional Council, the country’s highest court, struck down a previous attempt last year to bring back acetamiprid, ruling that the measure could pose risks to human health. That decision followed a petition signed by more than two million people opposing the pesticide’s reintroduction.
The previous bill had also been promoted by Duplomb, who argued that French agriculture needed additional tools to compete in international markets.